SEC Comment Letter 0000000000-24-007077 to Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070) (NEUP)
Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070)
Date: June 21, 2024 · CIK: 0001191070 · Accession: 0000000000-24-007077
AI Filing Summary & Sentiment
File numbers found in text: 333-280288
Letter
United States securities and exchange commission logo June 21, 2024 Spyridon Papapetropoulos, M.D. President and Chief Executive Officer Bionomics Limited 200 Greenhill Road Eastwood, SA 5063 Australia Re:Bionomics Limited Registration Statement on Form F-1 Filed June 18, 2024 File No. 333-280288 Dear Spyridon Papapetropoulos: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Chris Edwards at 202-551-6761 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Theodore Ghorra
Show Raw Text
United States securities and exchange commission logo
June 21, 2024
Spyridon Papapetropoulos, M.D.
President and Chief Executive Officer
Bionomics Limited
200 Greenhill Road
Eastwood, SA 5063
Australia
Re:Bionomics Limited
Registration Statement on Form F-1
Filed June 18, 2024
File No. 333-280288
Dear Spyridon Papapetropoulos:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Chris Edwards at 202-551-6761 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Theodore Ghorra